Integra LifeSciences Holdings Corp (Integra) is a medical technology company that develops and manufactures engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for the measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and extensive network of distributors worldwide. Integra is headquartered in Plainsboro, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Integra LifeSciences Holdings Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Integra LifeSciences Holdings Corp Company Overview
- Integra LifeSciences Holdings Corp Company Snapshot
- Integra LifeSciences Holdings Corp Pipeline Products and Ongoing Clinical Trials Overview
- Integra LifeSciences Holdings Corp - Pipeline Analysis Overview
- Business Description
- Integra LifeSciences Holdings Corp - Key Facts
- Integra LifeSciences Holdings Corp - Major Products and Services
- Integra LifeSciences Holdings Corp Pipeline Products by Development Stage
- Integra LifeSciences Holdings Corp Ongoing Clinical Trials by Trial Status
- Integra LifeSciences Holdings Corp Pipeline Products Overview
- 2-Piece Total Ankle Replacement System
- 2-Piece Total Ankle Replacement System Product Overview
- Abdominal Wall Matrix
- Abdominal Wall Matrix Product Overview
- Advanced Glenoid Platform
- Advanced Glenoid Platform Product Overview
- Advanced Shoulder System
- Advanced Shoulder System Product Overview
- Arkis AutoShunt
- Arkis AutoShunt Product Overview
- Biologic Vascular Graft
- Biologic Vascular Graft Product Overview
- Brain Mapping Device
- Brain Mapping Device Product Overview
- Conventional Pegged Glenoid
- Conventional Pegged Glenoid Product Overview
- Critical Care Neuro Monitoring System
- Critical Care Neuro Monitoring System Product Overview
- CSF Management Device
- CSF Management Device Product Overview
- CUSA Accessories
- CUSA Accessories Product Overview
- CUSA Clarity 2
- CUSA Clarity 2 Product Overview
- CUSA Ultrasonic Tissue Ablation System - Liver
- CUSA Ultrasonic Tissue Ablation System - Liver Product Overview
- Cytal Wound Matrix 1-Layer
- Cytal Wound Matrix 1-Layer Product Overview
- Cytal Wound Matrix 2-Layer
- Cytal Wound Matrix 2-Layer Product Overview
- Cytal Wound Matrix 3-Layer
- Cytal Wound Matrix 3-Layer Product Overview
- Cytal Wound Matrix 6-Layer
- Cytal Wound Matrix 6-Layer Product Overview
- Deltapaq Microcoil
- Deltapaq Microcoil Product Overview
- DuraSorb Monofilament Mesh - Breast Reconstruction
- DuraSorb Monofilament Mesh - Breast Reconstruction Product Overview
- DuraSorb Monofilament Mesh - Breast Reconstruction Clinical Trial
- ESS+ Rod
- ESS+ Rod Product Overview
- Flow Diverter
- Flow Diverter Product Overview
- Hydrocephalic Shunt
- Hydrocephalic Shunt Product Overview
- IMWD Single
- IMWD Single Product Overview
- Injectable Dermal Filler
- Injectable Dermal Filler Product Overview
- Integra Nextgen Nerve
- Integra Nextgen Nerve Product Overview
- LED 2
- LED 2 Product Overview
- MAYFIELD Composite
- MAYFIELD Composite Product Overview
- Medihoney Hydrogel Care
- Medihoney Hydrogel Care Product Overview
- MicroMatrix
- MicroMatrix Product Overview
- Nerve Guidance Conduit
- Nerve Guidance Conduit Product Overview
- NeuroGen 3D
- NeuroGen 3D Product Overview
- Next Gen LED
- Next Gen LED Product Overview
- Next Generation DuraSeal
- Next Generation DuraSeal Product Overview
- Next-Generation Shoulder Replacement System
- Next-Generation Shoulder Replacement System Product Overview
- PyroCarbon Hemi Shoulder
- PyroCarbon Hemi Shoulder Product Overview
- Pyrocarbon HRA
- Pyrocarbon HRA Product Overview
- Short Stem Shoulder System
- Short Stem Shoulder System Product Overview
- Stemless Shoulder System
- Stemless Shoulder System Product Overview
- Stereotaxy Device
- Stereotaxy Device Product Overview
- Ventricular Drainage Device
- Ventricular Drainage Device Product Overview
- Ventricular Drainage Device Clinical Trial
- Xenform Soft Tissue Repair Matrix
- Xenform Soft Tissue Repair Matrix Product Overview
- Integra LifeSciences Holdings Corp - Key Competitors
- Integra LifeSciences Holdings Corp - Key Employees
- Integra LifeSciences Holdings Corp - Key Employee Biographies
- Integra LifeSciences Holdings Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Integra LifeSciences Holdings Corp, Recent Developments
- Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment
- Aug 15, 2022: INTEGRA pipetting solutions streamline molecular diagnostics
- May 11, 2022: Hilco Redevelopment partners announces Integra to occupy new Braintree facility
- Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
- Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences
- Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results
- May 20, 2021: Integra LifeSciences Hosts Virtual Investor Day
- May 07, 2021: Integra LifeSciences To Host Virtual Investor Day On May 20, 2021
- Feb 19, 2021: Integra LifeSciences Announces Participation in Upcoming Investor Conferences
- Feb 18, 2021: Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Integra LifeSciences Holdings Corp Pipeline Products and Ongoing Clinical Trials Overview
- Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type
- Integra LifeSciences Holdings Corp Pipeline Products by Indication
- Integra LifeSciences Holdings Corp Ongoing Clinical Trials by Trial Status
- Integra LifeSciences Holdings Corp, Key Facts
- Integra LifeSciences Holdings Corp, Major Products and Services
- Integra LifeSciences Holdings Corp Number of Pipeline Products by Development Stage
- Integra LifeSciences Holdings Corp Pipeline Products Summary by Development Stage
- Integra LifeSciences Holdings Corp Ongoing Clinical Trials by Trial Status
- Integra LifeSciences Holdings Corp Ongoing Clinical Trials Summary
- 2-Piece Total Ankle Replacement System - Product Status
- 2-Piece Total Ankle Replacement System - Product Description
- Abdominal Wall Matrix - Product Status
- Abdominal Wall Matrix - Product Description
- Advanced Glenoid Platform - Product Status
- Advanced Glenoid Platform - Product Description
- Advanced Shoulder System - Product Status
- Advanced Shoulder System - Product Description
- Arkis AutoShunt - Product Status
- Arkis AutoShunt - Product Description
- Biologic Vascular Graft - Product Status
- Biologic Vascular Graft - Product Description
- Brain Mapping Device - Product Status
- Brain Mapping Device - Product Description
- Conventional Pegged Glenoid - Product Status
- Conventional Pegged Glenoid - Product Description
- Critical Care Neuro Monitoring System - Product Status
- Critical Care Neuro Monitoring System - Product Description
- CSF Management Device - Product Status
- CSF Management Device - Product Description
- CUSA Accessories - Product Status
- CUSA Accessories - Product Description
- CUSA Clarity 2 - Product Status
- CUSA Clarity 2 - Product Description
- CUSA Ultrasonic Tissue Ablation System - Liver - Product Status
- CUSA Ultrasonic Tissue Ablation System - Liver - Product Description
- Cytal Wound Matrix 1-Layer - Product Status
- Cytal Wound Matrix 1-Layer - Product Description
- Cytal Wound Matrix 2-Layer - Product Status
- Cytal Wound Matrix 2-Layer - Product Description
- Cytal Wound Matrix 3-Layer - Product Status
- Cytal Wound Matrix 3-Layer - Product Description
- Cytal Wound Matrix 6-Layer - Product Status
- Cytal Wound Matrix 6-Layer - Product Description
- Deltapaq Microcoil - Product Status
- Deltapaq Microcoil - Product Description
- DuraSorb Monofilament Mesh - Breast Reconstruction - Product Status
- DuraSorb Monofilament Mesh - Breast Reconstruction - Product Description
- DuraSorb Monofilament Mesh - Breast Reconstruction - The Safety and Effectiveness of DuraSorb for Reinforcement in Patients Undergoing Prosthetic Breast Reconstruction
- ESS+ Rod - Product Status
- ESS+ Rod - Product Description
- Flow Diverter - Product Status
- Flow Diverter - Product Description
- Hydrocephalic Shunt - Product Status
- Hydrocephalic Shunt - Product Description
- IMWD Single - Product Status
- IMWD Single - Product Description
- Injectable Dermal Filler - Product Status
- Injectable Dermal Filler - Product Description
- Integra Nextgen Nerve - Product Status
- Integra Nextgen Nerve - Product Description
- LED 2 - Product Statu
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- MiMedx Group Inc
- LifeCell Corp
- Smith & Nephew Plc
- Nexstim Plc
- Becton Dickinson and Co
- Stryker Corp
